Healthcare -
Biotechnology - NASDAQ - US
$ 0.5008
-4.32 %
$ 61.9 M
Market Cap
-0.83
P/E
MRSN - CASH & EQUIVALENTS
Cash & Equivalents MRSN - Mersana Therapeutics, Inc.
175 M
LAST VALUE
-0.96%
2 YEAR CAGR
23.96%
5 YEAR CAGR
0.00%
10 YEAR CAGR